7/29/10
Cerus Corporation Reports Second Quarter Revenues more >
7/12/10
Cerus to Release Second Quarter Results on July 29, 2010 more >
6/30/10
Study Results Presented at International Transfusion Congress Highlight Cerus' Progress... more >
About Cerus Corporation
2010 Annual Meeting
Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. Cerus currently markets the INTERCEPT Blood System for both platelets and plasma in Europe, Russia, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is currently in clinical development.
> More about Cerus
Meeting information and 2009 Annual Report are now available.
.png)
Meeting information and 2009 Annual Report are now available.